Most Ditch GLP-1 Drugs for Weight Loss Within a Year
Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly higher for patients without versus with type 2 diabetes (64.8% vs 46.5%), reported Ezekiel J. Emanuel, MD, PhD, of the University of Pennsylvania in Philadelphia, and colleagues.
Weight loss drugs like Ozempic and Wegovy dominated 2024. Securing insurance to cover the costs is a different challenge ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
MarketBeat on MSN2d
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss TrendsThe supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...
The star of Clinic Secret’s weight loss regimen is GLP-1 (glucagon-like peptide-1 ... a licensed physician who can guide them toward the best treatment plan. Is Clinic Secret Right for You ...
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...
Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...
"Our new line of doctor-formulated GLP-1 Support supplements is designed to fill those gaps and help users stay nourished, energized, and confident while on their weight-loss journey." ...
Zero Doubt Club, a Northeast Ohio-based wellness center, has introduced a GLP-1 weight-loss program that combines medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback